ArticleTrials2025

Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis.

Ema-Louise Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.